 |
 |
 |
 |
 |
 |
 |
 |
 |
Snowdon Inc. is a drug discovery and development company that is focused on three major therapeutic areas with substantial market potential: cancer, acute and chronic pain, and infectious diseases. These diseases and conditions cause immense suffering, economic hardship, and loss of life among millions of people every day. In each of these therapeutic areas, Snowdon has discovered prospective drug candidates that address the urgent need for safe and effective medicines. [more]
Recent News
October 11, 2007: Snowdon, Inc. was awarded a $130,000 Phase I Small Business Innovation Research Award from the National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) to support further development of the company's novel therapies for the prevention and treatment of Alzheimer's and Parkinson's diseases. [more]
July 9, 2007: Tiny Snowdon Bags $1 Million in Just Eight Months... The startup uses UMDNJ technology to develop a novel method for discovering drugs (NJBIZ Staff, Thomas Gaudio) [more]
June 23, 2007: Snowdon, Inc., announced today that it received a two-year $500,000 Edison Innovation Award grant from the New Jersey Commission on Science & Technology (NJCST). [more]
March 22, 2007: Snowdon, Inc. secured $500,000 in venture capital funding from the Foundation Venture Capital Group LLC (FVCG). [more]
home | company overview | therapeutic areas | veterinary care | our technology | pipeline | about us | contact us